Yakult Group

Yakult Honsha is a prominent Japanese company operating in the food, beverage, and pharmaceutical sectors, best known for its pioneering work in probiotics. The company's pharmaceutical division focuses primarily on oncology, where it has established a strong presence through the development and commercialization of essential chemotherapy agents like Elplat (oxaliplatin) and Campto (irinotecan). Beyond its core oncology portfolio, Yakult leverages its extensive research into the Lactobacillus casei Shirota strain to develop health-promoting products that target the gut microbiome. The company maintains strategic partnerships with global pharmaceutical firms to distribute and co-promote cancer therapies in the Japanese market. Yakult's dual focus on preventive health through probiotics and therapeutic intervention through oncology drugs defines its unique position in the healthcare landscape.